LDL cholesterol as a causal agent of atherosclerosis Juan Pedro-Botet; Elisenda Climent; David Benaiges;

Long-term treatment persistence and maintained reduction of LDL-cholesterol levels with evolocumab over 30 months: Results from the Spanish cohort of the European prospective HEYMANS study Agustín Blanco Echevarría; Juan De Dios García Díaz; Assumpta Caixas; Núria Plana Gil; Miguel Ángel Rico Corral; Ian Bridges; Nafeesa Dhalwani; Sònia Gatell Menchen; Kausik K. Ray;

How to achieve LDL cholesterol goals with the funding criteria for new lipid-lowering drugs? Antón González-Guerrero; Elisenda Climent; David Benaiges; Juan Pedro Botet;